Company / Shareholders' Equity
Core Scientific, Inc./tx Shareholders' Equity History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
-$962.7M
FY2025
5-year range
-$962.7M / $1.3B
FY2021-FY2025
Trend
-2.1%
vs FY2024
Sector context
#401 of 402
Financials
What the data says
Core Scientific, Inc./tx reports negative total equity of -$963M in FY2025. Negative equity can occur when accumulated losses exceed contributed capital, as reported in the balance sheet from the SEC filing.
Based on SEC 10-K filings.
-$963M in FY2025.
Declined from -$597M to -$963M over the past 2 years.
Financials sector context is included.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 0% in FinancialsTop 100% of 402This company -$962.7M Sector average $11.2B
▼
-108.6% below sector average
Key checks
Key Insights
- Core Scientific, Inc./tx's shareholders' equity has declined for 4 consecutive years.
- In FY2025, shareholders' equity decreased 2.1% year-over-year.
- Ranks #401 out of 402 companies in the Financials sector.
- Peak shareholders' equity was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score -1.77 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$962.7M | -2.1% |
| FY2024 | -$943.0M | -58.0% |
| FY2023 | -$596.9M | -45.8% |
| FY2022 | -$409.3M | -130.5% |
| FY2021 | $1.3B | +1403.2% |
| FY2020 | $89.2M | - |
As of FY2025 · SEC 10-K · Updated Mar 29, 2026